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Objectives. The present study was designed to investigate which 
characteristics ofanginal symptoms or exercise test results could 
predict he favorable anti-ischemic effect of the beta-adrenergic 
blocking agent metoprolol and the calcium antagonist nifedipine 
in patients with stable angina pectoris. 
Background. The characteristics ofanginal symptoms and the 
results of exercise testing are considered of great importance for 
selecting medical treatment in patients with chronic stable angina 
pectoris. However, little information is available on how this first 
evaluation may be used to select he best pharmacologic approach 
in individual patients. 
Methods. In this prospective multicenter study, 280 patients 
with stable angina pectoris were enrolled in 25 European centers. 
After baseline evaluation, consisting of an exercise test and a 
questionnaire investigating patients' anginal symptoms, the pa- 
tients were randomly allocated to double-blind treatment for 
6 weeks with either metoprolol (Controlled Release, 200 mg once 
daily) or nifedipine (Retard, 20 mg twice daily) according to a 
parallel group design. At the end of this period, exercise tests were 
repeated 1to 4 h after drug intake. 
Results. Both metoprolol and nifedipine prolonged exercise 
tolerance over baseline levels; the improvement was greater in the 
patients receiving metoprolol (p < 0.05). Multivariate analysis 
revealed that low exercise tolerance was the only variable associ- 
ated with a more favorable ffect within each treatment group. 
Metoprolol was more effective than nifedipine in patients with a 
lower exercise tolerance or with a higher ate-pressure product at 
rest and at ischemic threshold. None of the characteristics of 
anginal symptoms or exercise test results predicted a greater 
efficacy of nifedipine over metoprolol. 
Conclusions. The results of a baseline xercise test, but not the 
characteristics ofanginal symptoms, may offer useful information 
for selecting medical treatment in stable angina pectoris. 
(J Am CoU Cardiol 1995;25:1516-21) 
In everyday clinical practice, the decision as to what initial 
medical treatment to give a patient with stable angina pectoris 
is usually taken after assessing the symptoms and having seen 
the results of an exercise test. However, little information is
available on how this first evaluation may be used to select he 
best pharmacologic approach in individual patients. This 
multicenter trial was designed to investigate whether the 
characteristics of anginal symptoms and exercise testing were 
capable of predicting a favorable response to treatment with 
either the beta-adrenergic blocking agent metoprolol or the 
calcium antagonist nifedipine. These two agents were selected 
as prototypes of two different approaches aimed at reducing 
the discrepancy between myocardial oxygen demand and sup- 
ply, the pathophysiologic mechanism ofstable angina pectoris. 
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Patient selection. For this multicenter t ial, 290 patients 
with stable angina pectoris were enrolled in 25 European 
centers. To qualify for enrollment, patients had to report 
typical anginal symptoms, stable for >_6 months, and show a 
positive response to exercise stress testing, with >_3 min of 
exercise tolerance. The exclusion criteria included age >75 
years, recent (<6 months) myocardial infarction, heart failure 
and angina of such severity that even temporary withdrawal of 
antianginal therapy was not feasible. Patients with serious 
concomitant diseases, including obstructive lung disease and 
insulin-dependent diabetes mellitus, or with hemoglobin 
levels <11 g/dl or systolic blood pressure <100 mm Hg, were 
also excluded. Only patients with sinus rhythm and an analyz- 
able ST segment at electrocardiography were included. 
Study protocol. After informed consent was obtained from 
the patient, all previous cardiovascular medications were grad- 
ually discontinued over a 2-week placebo run-in period during 
which only sublingual nitroglycerin was allowed (for interrup- 
tion of anginal attacks). At the end of this run-in period, a 
baseline valuation was performed by means of a specifically 
designed questionnaire and an exercise stress test. The patients 
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were then randomly allocated to double-blind treatment for 6 
weeks with either metoprolol (Controlled Release, 200 mg 
once daily) or nifedipine (Retard, 20 mg twice daily), according 
to a parallel group design. After this treatment period, the 
exercise test was repeated, according to the same protocol, 1 to 
4 h after drug intake. 
Angina questionnaire. A questionnaire comprising 13 
questions investigating the patients' anginal symptoms (Table 
1) was administered bythe physician in charge of the study at 
each center. Patients were requested to read each question 
carefully and to mark the appropriate position on a 100-ram 
visual analog scale representing the range of possible answers; 
the responses were quantified in ram. Two mirror questions 
(questions 2 and 5) were used to evaluate the patients' 
reliability in reporting symptoms. The reliability of the ques- 
• tionnaire was also tested by comparing question 1 with the 
frequency of anginal attacks noted in the diary cards and by 
comparing question 2b with total exercise time during the 
baseline xercise test. 
Exercise test. Bicycle exercise tests were performed at an 
initial work load of 30 W, subsequently increased by 10 W 
every minute. A standard 12-lead electrocardiogram (ECG) 
and blood pressure levels were recorded immediately before 
the test, at l-rain intervals during exercise and for at least he 
1st 10 min of the recovery phase. An estimate of myocardial 
oxygen consumption was made from the rate-pressure product 
obtained by multiplying heart rate and systolic blood pressure. 
The exercise test was stopped at the occurrence of moderate 
to severe angina, dyspnea, exhaustion or ST segment 
depression _>3 ram. Horizontal or downsloping ST segment 
depression >1 mm for 0.08 s after the J point, with or without 
chest pain, was considered a positive exercise test result. The 
time to 1-mm ST segment depression was used to define the 
patient's i chemic threshold. For the subsequent exercise tests 
performed uring treatment, total exercise time was used to 
evaluate patients who did not manifest 1-mm ST segment 
depression. 
Diary cards. Throughout the study, the patients recorded 
the occurrence of anginal attacks on diary cards that were 
collected at the end of the run-in period and after 2 and 
6 weeks of double-blind treatment. The mean weekly number 
of anginal attacks during each period was calculated for each 
patient. Compliance with the therapeutic regimen was evalu- 
ated at each visit by counting the number of returned tablets. 
Good compliance was defined as 80% to 120% of scheduled 
tablet consumption. To ensure the standardization f data 
collection and exercise testing, a member of the Steering 
Committee visited all participating centers during the planning 
phase of the study. Special care was taken in translating the 
questionnaire into local languages. 
Statistical analysis. Statistical analysis was performed on 
the 264 patients completing the study (per-protocol analysis). 
The data are presented as mean values with 95% confidence 
intervals (CI). The absolute difference in time to l-ram ST 
segment depression at week 6 in comparison with baseline was 
the main efficacy variable. The least squares method was 
applied to assess correlations between 1) the questionnaire and 
exercise variables, and 2) the changes in time to l-ram ST 
segment depression after treatment. Multivariate analysis was 
used to determine whether any anamnestic orexercise variable 
was independently related to changes in time to 1-mm ST 
segment depression from baseline to week 6. The analysis was 
carried out by using stepwise regression and included those 
variables found to be significant at univariate analysis. The 
anamnestic variables included all 13 questions hown in 
Table 1. The exercise variables considered were time to l-ram 
ST segment depression, time to angina, total exercise time, 
rate-pressure product at rest and rate-pressure product at 
ischemic threshold. To assess whether any anamnestic or 
exercise variable was capable of identifying subgroups of 
patients who were likely to respond more favorably to either of 
the two treatments, he two groups were classified into tertiles 
of approximately equal numbers of patients based on the 
values of the visual analog scales and exercise variables. 
Changes in time to 1-mm ST segment depression from baseline 
to week 6 were compared between treatment groups within 
each low, middle and high tertile. 
Resu l ts  
Patients. Of the 290 enrolled patients, 10 were not ran- 
domized; 6 of the 10 were unwilling to participate because of 
increased angina during the run-in period, 2 did not meet 
inclusion criteria and 2 were not included for unknown rea- 
sons. Two hundred eighty patients entered the double-blind 
phase; 264 completed the study. The reasons for dropout are 
listed in Table 2. Compliance was considered good in 95% of 
patients and did not differ between groups. Table 3 shows the 
baseline characteristics of the patients completing the study. 
The patients howed a variable proportion of effort-induced 
versus rest angina (as evaluated by their answers to question 2) 
and were distributed over a wide range of levels of exercise 
tolerance (Fig. 1). 
Validation of the angina questionnaire. The significant 
correlation (p < 0.0001) found between the responses to 
questions 2 and 5 demonstrated good within-patient reliability 
in reporting symptoms. The reliability of the questionnaire 
itself was demonstrated by the significant correlation (p < 
0.0001) between angina frequency (as evaluated by question 1) 
and the weekly number of anginal attacks during the run-in 
period (as measured by diary cards), as well as by the signifi- 
cant correlation (p < 0.0001) between patient-reported xer- 
cise tolerance (question 2b) and the total exercise time mea- 
sured by the stress test at the end of the run-in period. 
Effect of treatment on exercise tolerance and angina fre- 
quency. Both metoprolol and nifedipine increased time to 
l-ram ST-segment depression over baseline value at week 6; 
the improvement was greater (p < 0.05) in the patients 
receiving metoprolol (Table 4). Fourteen percent of the pa- 
tients receiving metoprolol (95% CI 9% to 21%) and 21% of 
those receiving nifedipine (95% CI 14% to 29%) did not show 
_>l-ram ST segment depression during treatment. Metoprolol 
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Table 1. Angina Pectoris Questionnaire Based on Visual Analog Scales 
Q1. Estimate the frequency of episodes of pain, ache or pressure in your chest and tick the appropriate place on the line below. 
i . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
Very seldom Very frequent 
(once a month or less) (several times every day) 
Q2. Estimate the proportion of episodes occurring during physical activity and tick the appropriate place on the line below 
O% 100% 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
None All 
Q2b. If symptoms occur during physical activity, estimate the degree of physical activity necessary to precipitate them. Tick the appropriate place on the line 
below. 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
Very light exercise Very hard exercise 
(any physical activity) (running uphill at a hard pace) 
Q3. Estimate the proportion of episodes occurring only after physical activity and tick the appropriate place on the line below. 
0% 100% 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
None All 
Q3b. If symptoms occur after physical activity, estimate the degree of physical activity necessary to precipitate them. Tick the appropriate place on the line below, 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
Very light exercise Very hard exercise 
(after running uphill at a hard pace) (after any physical activity) 
Q4. Do these symptoms get worse in cold and/or windy weather? Tick the appropriate place on the line below. 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
Never Always 
Q5. Estimate the proportion of episodes occurring at rest and tick the appropriate place on the line below. 
0% 100% 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  i 
None All 
Q6. Estimate the proportion of episodes occurring during the night and tick the appropriate place on the line below. 
0% 100% 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
None All 
Q6b. If symptoms occur during the night, estimate when they usually occur and tick the appropriate place on the line below (more than one tick is allowed). 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
In the evening In the morning 
(right after going to bed) (when waking up) 
Q7. Estimate the proportion of episodes occurring under any of the following circumstances: anxiety, worry, when watching exciting TV programmes or in 
connection with conflicts at home or work. 
0% 100% 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
None All 
Q8. Estimate the proportion of episodes occurring after meals and tick the appropriate place on the line below. 
0% 100% 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
None All 
Q9. Estimate the usual duration of the episodes and tick the appropriate place on the line below. 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  [ 
Very short Very long 
(a few seconds) (more than 10 minutes) 
Q10. Estimate the change in the intensity of the symptoms from time to time. 
I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  I 
Always the same intensity Great variations in intensity 
Q = question. 
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Table 2. Reasons for Dropout 
Cardiovascular Events Side Effects Nondrug Related 
Metoprolol 
Myocardial infarction (1) Itching (1) Pharyngitis (1) 
Unstable angina (1) Depression (1) 
Stroke (1) 
Syncope (1) 
Nifedipine 
Myocardial infarction (1) Palpitation (3) Elective coronary 
Unstable angina (2) Headache (1) revascularization (1) 
Ankle edema (1) 
Numbers in parentheses denote the number of patients. 
and nifedipine significantly increased total exercise time and 
time to angina, and they decreased the mean weekly number of 
anginal attacks to the same extent (Table 4). 
Relation between symptoms or exercise test variables and 
effect of treatment. The main issue addressed in our study 
concerned the possible relation between symptoms or exercise 
test variables and the changes in time to 1-mm ST segment 
depression with either metoprolol or nifedipine. In the meto- 
prolol group, greater increases in time to l - ram ST segment 
depression were observed in patients reporting infrequent 
anginal attacks (question 1) (p < 0.02) that were not affected 
by cold (question 4) (p < 0.0005) or by stress situations 
(question 7) (p < 0.02). Lower exercise tolerance at baseline (p 
< 0.002) and a higher rate-pressure product at rest (p < 0.02) 
were also associated with a better response to metoprolol. 
Table 3. Demographic and Baseline Exercise Test Characteristics of 
All Patients Included in the Per-Protocol Analysis 
Metoprolol Nifedipine 
(n = 138) (n = 126) 
Age (yr) 59 _+ 8 59 +- 8 
Men/Women 116/22 100/26 
Hypertension 22 19 
Diabetes 6 9 
Smoker 85 79 
Previous MI 11 15 
NYHA class 
II 42 48 
III 87 '70 
IV 9 8 
Coronary arteriography 32 40 
CAD 
1-vessel 7 11 
2-vessei 8 14 
3-vessel 14 12 
Left main 3 3 
Time to 1-mm ST $ (s) 360 _+ 168 374 2 145 
Time to angina (s) 342 _+ 161 356 -+ 154 
Total exercise time (s) 494 _+ 181 507 _+ 158 
Anginal episodes/wk (no.) 5.7 -+ 6.6 6.3 + 7.8 
Data are expressed asmean value _+ SD or number of patients. CAD = 
coronary artery disease; MI = myocardial infarction; NYHA class = New York 
Heart Association functional c ass; ST $ = ST segment depression. 
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Figure 1. Top, Patient distribution according to the proportion of 
effort-induced anginal episodes as evaluated by question 2 of the 
questionnaire (Table 1). Bottom, Patient distribution according to total 
exercise time measured at the end of the run-in period. Patients with 
<3 rain of exercise tolerance were not included in the study. 
Among the patients randomized to nifedipine, those reporting 
angina not affected by cold (question 4) (p < 0.03) and those 
with lower exercise tolerance at baseline (p < 0.005) showed a 
greater increase in ischemic threshold. Stepwise regression 
Table 4. Effect of Treatment on Exercise Variables and Weekly 
Number of Anginal Attacks: Changes From Baseline 
Metoprolol Nifedipine 
(n = 138) (n = 126) p Value* 
Time to 1 mm ST ~, (s) 68 42 < 0.05 
(45 to 91) (16 to 67) 
Time to angina (s) 68 43 NS 
(43 to 94) (17 to 69) 
Total exercise time (s) 44 33 NS 
(25 to 64) (9 to 57) 
Anginal episodes/week (no.) 1.7 -1.5 NS 
(-2.4 to -0.98) (-2 to -0.6) 
*p values refer to comparisons between metoprolol and nifedipine. Data are 
expressed as mean difference (95% confidence interval) from baseline value. 
ST ,L = ST segment depression. 
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Figure 2. Changes in time to 1-mm ST segment depression after 6 
weeks of treatment with metoprolol (dosed circles) or nifedipine 
(open circles). Bars indicate 95% confidence intervals. When a bar 
does not cross the 0 axis, the difference from baseline isstatistically 
significant a a level of p < 0.05. Comparisons between drugs are made 
within each low, middle and high tertile of the baseline xercise 
variables. Numbers in parentheses denote the range of each tertile. 
*p < 0.05 for comparisons between metoprolol and nifedipine within 
each tertile. 
analysis demonstrated that lower exercise tolerance at baseline 
was the only variable independently related to a better esponse 
to both metoprolol (p < 0.002) and nifedipine (p < 0.04). 
Tertile analysis (Fig. 2) showed that patients in the low 
tertiles of total exercise time and time to 1-mm ST segment 
depression, and those in the high tertiles of rate-pressure 
product at rest and at ischemic threshold, had a significantly 
greater increase in exercise tolerance with metoprolol than 
with nifedipine (p < 0.05). None of the questionnaire - 
sponses or exercise variables identified subgroups of patients 
who responded more favorably to nifedipine than to metoprolol. 
Discussion 
Pathophysiology of stable angina pectoris and selection of 
medical treatment. Stable angina pectoris is caused by a 
discrepancy between the demand and supply of myocardial 
oxygen due to coronary artery disease (1). Pharmacologic 
improvement of the supply-demand balance may be achieved 
by using drugs such as beta-adrenergic blocking agents, which 
reduce oxygen consumption (2,3), or drugs such as dihydro- 
pyridine calcium antagonists, which increase coronary blood 
flow (4-6). Ideally, the choice of initial pharmacologic treat- 
ment should be based on the prevailing cause of the ischemic 
episodes in each individual patient (7,8). However, in everyday 
clinical practice, it is not easy to demonstrate he precise 
mechanism that causes transient myocardial ischemia. It has 
been suggested that one logical approach is to take a detailed 
history and to assess the ischemic threshold by means of a 
standardized exercise test. According to this view (8), when 
angina occurs at a predictable level of effort, it may be 
presumed that myocardial ischemia is primarily caused by an 
increase in oxygen demand in the face of a fixed supply, and a 
beta-blocker would be the drug of choice. Conversely, when 
angina occurs at unpredictable levels of effort, or even at rest 
or during the night, it may be presumed that transient impair- 
ment of blood supply due to coronary vasoconstriction plays a 
role in its development, and that calcium antagonist treatment 
is preferable (9). 
Relation between symptoms, exercise tolerance and drug 
etficacy. Using an objective questionnaire and exercise test 
data, we investigated those characteristics that might predict a 
more favorable response to either of these drugs in terms of 
exercise ischemic threshold. Metoprolol was more effective 
than nifedipine in patients with lower exercise tolerance and 
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higher indexes of myocardial oxygen consumption, but none of 
the exercise variables, nor any of the symptoms commonly 
considered indicative of a transient impairment of blood supply 
(such as rest angina, variable angina threshold or nocturnal 
angina (9,10)), predicted any greater efficacy of nifedipine. 
Although the choice pf a beta-blocker would seem war- 
ranted in patients with stable angina who have a lower exercise 
tolerance or higher indexes of myocardial oxygen consump- 
tion, we found that the patients with the poorest exercise 
tolerance at baseline received the greatest benefit from both 
anti-ischemic treatments. The explanation may be that patients 
with lower exercise tolerance are mostly limited by myocardial 
ischemia, and thus pharmacologic control of the oxygen supply/ 
demand ratio is more likely to affect exercise tolerance in this 
group. In patients with greater exercise tolerance at baseline, 
other factors such as dyspnea, exhaustion or lack of training 
may also limit exercise performance, and these factors are less 
likely to be influenced by pharmacologic ntervention. 
Efficacy of metoprolol versus nifedipine. Although meto- 
prolol was generally more effective than nifedipine, the pro- 
portion of patients who terminated their exercise test without 
showing _>l-ram ST segment depression was greater in the 
nifedipine group. This may be due to the nonspecific effect of 
beta-blockers, which act primarily by reducing myocardial 
oxygen consumption. This mechanism is likely to produce an 
anti-ischemic effect regardless of the pathogenetic mechanism 
of ischemia in individual patients. Nifedipine is less effective 
than metoprolol in reducing myocardial oxygen consumption 
but may be extremely effective in those patients in whom a 
vasoconstrictive mechanism is involved. The results of the 
present study are in keeping with this hypothesis as metoprolol 
was significantly more effective than nifedipine in patients with 
lower exercise tolerance and higher indexes of myocardial 
oxygen consumption. Unfortunately, on the basis of our data, 
those patients in whom nifedipine has an excellent anti-isch- 
emic effect cannot he identified from their symptoms and 
exercise test data; however, other characteristics, uch as the 
response to the provocative testing of coronary vasoconstric- 
tion, have been shown to predict a favorable response to 
calcium antagonists (11). 
Clinical implications. We conclude that beta-blocker ther- 
apy seems to be warranted in patients with stable angina with 
a lower exercise tolerance and a higher index of myocardial 
oxygen consumption; in patients with greater exercise toler- 
ance, pharmacologic manipulation of the oxygen/supply de- 
mand ratio may be less effective and less predictable. 
Appendix 
The IMAGE (International Multicenter Angina 
Exercise) Study Group 
Denmark: P. Henningsen, K. Rasmussen, K. Sorensen (Arhus Kom- 
munehospital, Kardiologisk afdeling, Arhus); K. Egstrup, O. B. Ras- 
mussen, P. Pless (Odense Sygehus, Medicinsk afdeling B, Odense); 
J. Kyst Madsen, I. Jacobsen (Rigshospitalet, Medicinsk afdeling D, 
Kobenhavn); P. Lomholt, A. Johansen, V. Bager (Randers Centralsy- 
gebus, Medicinsk afdeling M, Randers); H. Vejby-Christenson, V.
Mogensen, K. Hjollund Jensen, M. Kjellgaard (Herning Centralsyge- 
bus, Medicinsk afdeling, Herning); M. Scheibel, J. Nielsen (Kjellerup 
Sygehus, Medicinsk afdeling, Kjellerup); A. Galloe, J. R. Petersen 
(Bispebjerg Hospital, Medicinsk afdeling P, Kobenhavn); B. Jastrup, 
A. Lange (Odder Sygehus, Medicinsk afdeling, Odder); J. Soltoft, M. 
Hojklint, H. Jespersen, N. Brunsgaard (Viborg Sygehus, Medicinsk 
afdeling, Viborg); B. Sigurd, I. Norgard (Nykoping Falster Centralsy- 
gehus, Medicinsk afdeling, Nykoping Falster). 
Norway: E. A. Bae (Med avd, Fylkessykehnset i Volda, Volda); 
P. M. Schjelderup-Mathiesen (I tern Med, Halden); T. V. Holm (Med 
avd, Sentralsykehuset for Ostfold, Fredrikstad); E. Anker (Med avd, 
Kongsvinger Sykehus, Kongsvinger); S. Sire (Statens Arbeidsmarkeds 
Institutt, Oslo); N. Lid (Med avd, Notodden Sykehus, Notodden); C. 
von Brandis, T. M. Omland (Med avd, Sentralsykehuset i Rogaland, 
Stavanger); P. M. Johannenssen, H. Haugland (Bergen Hjertesenter, 
Bergen); P. A. Sirnes (Med avd A, Aker Sykehus, Oslo). 
Sweden: N. Rehnqvist (Department of Medicine, Danderyd Hos- 
pital, Danderyd); I. M. Wahlqvist, B. Lundgren (Medical Department, 
AB Hassle, Molndal). 
Italy: G. Specchia, D. Ardissino, P. Barberis (Divisione di Cardio- 
logia, IRCCS, Policlinico S. Matteo, Pavia); M. P. Giordano, G. 
Roncarolo (Divisione di Cardiologia, Ospedale S. Andrea, Vercelli); 
G. A. Feruglio, M. Rosenfeld, G. Slavich (Istituto di Cardiologia, 
Ospedale S. Maria della Misericordia, Udine); A. L'Abbate, E. Orsini, 
P. Marraccini (Istituto di Fisiologia Clinica CNR, Pisa); S. Savonitto, 
P. A. Merlini (II Divisione di Cardiologia, Ospedale Niguarda C~i 
Granda, Milano). 
Spain: J. Julia, P. Sanchez (Hospital de La Cruz Roja de Hospitalet 
de Llobregat, Barcelona). 
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